Diabetes mellitus type 2
Boston Scientific Announces Completion of Enrollment in Landmark Clinical Trial Comparing Drug-Eluting Stents To … (PR Newswire via Yahoo! Finance)
Boston Scientific Corporation today announced that it has completed enrollment in its SYNTAX clinical trial.
Add to: | Technorati | Digg | del.icio.us | Yahoo | BlinkList | Spurl | reddit | Furl |
